Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine
Summary
HONG KONG and HANGZHOU, China, April 30, 2026 /PRNewswire/ -- Hangzhou Diagens Biotech Co., Ltd. (HKEX: 2526, 'Diagens'), a pioneer in medical imaging foundatio...
Description
HONG KONG and HANGZHOU, China, April 30, 2026 /PRNewswire/ -- Hangzhou Diagens Biotech Co., Ltd. (HKEX: 2526, 'Diagens'), a pioneer in medical imaging foundatio...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source